{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:52:02Z","timestamp":1771005122983,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,1,26]],"date-time":"2008-01-26T00:00:00Z","timestamp":1201305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s10620-007-0127-4","type":"journal-article","created":{"date-parts":[[2008,1,25]],"date-time":"2008-01-25T12:50:07Z","timestamp":1201265407000},"page":"2059-2065","source":"Crossref","is-referenced-by-count":20,"title":["Primary Prevention of Adverse Gastroduodenal Effects from Short-Term Use of Non-Steroidal Anti-Inflammatory Drugs by Omeprazole 20\u00a0mg in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Study"],"prefix":"10.1007","volume":"53","author":[{"given":"Jay C.","family":"Desai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shefali M.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyralee","family":"Goo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel A.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Bodian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence B.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Aisenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,26]]},"reference":[{"issue":"8","key":"127_CR1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/j.1572-0241.2005.41833.x","volume":"100","author":"A Lanas","year":"2005","unstructured":"Lanas A, Perez-Aisa MA, Feu F et al (2005) A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol 100(8):1685\u20131693","journal-title":"Am J Gastroenterol"},{"issue":"24","key":"127_CR2","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","volume":"340","author":"MM Wolfe","year":"1999","unstructured":"Wolfe MM, Lichtenstein DR, Singh G (1999) Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340(24):1888\u20131899","journal-title":"N Engl J Med"},{"issue":"4","key":"127_CR3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0016-5085(93)90277-J","volume":"104","author":"D Henry","year":"1993","unstructured":"Henry D, Robertson J (1993) Nonsteroidal anti-inflammatory drugs and peptic ulcer hospitalization rates in New South Wales. Gastroenterology 104(4):1083\u20131091","journal-title":"Gastroenterology"},{"issue":"4","key":"127_CR4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-114-4-257","volume":"114","author":"MR Griffin","year":"1991","unstructured":"Griffin MR, Piper JM, Daugherty JR et al (1991) Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 114(4):257\u2013263","journal-title":"Ann Intern Med"},{"issue":"9435","key":"127_CR5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)16894-3","volume":"364","author":"ME Farkouh","year":"2004","unstructured":"Farkouh ME, Kirshner H, Harrington RA et al (2004) Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet 364(9435):675\u2013684","journal-title":"Lancet"},{"issue":"10","key":"127_CR6","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","volume":"284","author":"FE Silverstein","year":"2000","unstructured":"Silverstein FE, Faich G, Goldstein JL et al (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284(10):1247\u20131255","journal-title":"JAMA"},{"issue":"5","key":"127_CR7","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1572-0241.2005.41465.x","volume":"100","author":"C Hawkey","year":"2005","unstructured":"Hawkey C, Talley NJ, Yeomans ND et al (2005) Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors. Am J Gastroenterol 100(5):1028\u20131036","journal-title":"Am J Gastroenterol"},{"issue":"7472","key":"127_CR8","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/bmj.38232.680567.EB","volume":"329","author":"L Hooper","year":"2004","unstructured":"Hooper L, Brown TJ, Elliott R et al (2004) The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review. BMJ 329(7472):948","journal-title":"BMJ"},{"issue":"4","key":"127_CR9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1572-0241.2006.00499.x","volume":"101","author":"JM Scheiman","year":"2006","unstructured":"Scheiman JM, Yeomans ND, Talley NJ et al (2006) Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol 101(4):701\u2013710","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"127_CR10","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1053\/gast.2002.36013","volume":"123","author":"L Laine","year":"2002","unstructured":"Laine L, Bombardier C, Hawkey CJ et al (2002) Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis. Gastroenterology 123(4):1006\u20131012","journal-title":"Gastroenterology"},{"issue":"1","key":"127_CR11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/aje\/kwh005","volume":"159","author":"LA Garcia Rodriguez","year":"2004","unstructured":"Garcia Rodriguez LA, Hernandez-Diaz S (2004) Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Am J Epidemiol 159(1):23\u201331","journal-title":"Am J Epidemiol"},{"issue":"3","key":"127_CR12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2036.2004.02078.x","volume":"20","author":"A Lanas","year":"2004","unstructured":"Lanas A (2004) Economic analysis of strategies in the prevention of non-steroidal anti-inflammatory drug-induced complications in the gastrointestinal tract. Aliment Pharmacol Ther 20(3):321\u2013331","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"127_CR13","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/ar2207","volume":"9","author":"HH Vonkeman","year":"2007","unstructured":"Vonkeman HH, Fernandes RR, van der PJ et al (2007) Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case control study. Arthritis Res Ther 9(3):R52","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"127_CR14","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.cgh.2006.08.016","volume":"4","author":"JL Goldstein","year":"2006","unstructured":"Goldstein JL, Howard KB, Walton SM et al (2006) Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications. Clin Gastroenterol Hepatol 4(11):1337\u20131345","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"127_CR15","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1053\/j.gastro.2005.08.003","volume":"129","author":"NS Abraham","year":"2005","unstructured":"Abraham NS, El Serag HB, Johnson ML et al (2005) National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. Gastroenterology 129(4):1171\u20131178","journal-title":"Gastroenterology"},{"issue":"Suppl 3","key":"127_CR16","first-page":"iii23","volume":"42","author":"MC Sturkenboom","year":"2003","unstructured":"Sturkenboom MC, Burke TA, Dieleman JP et al (2003) Underutilization of preventive strategies in patients receiving NSAIDs. Rheumatology (Oxford) 42(Suppl 3):iii23-iii31","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"127_CR17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/00002512-200724020-00004","volume":"24","author":"A Lanas","year":"2007","unstructured":"Lanas A, Ferrandez A (2007) Inappropriate prevention of NSAID-induced gastrointestinal events among long-term users in the elderly. Drugs Aging 24(2):121\u2013131","journal-title":"Drugs Aging"},{"issue":"2","key":"127_CR18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2036.2007.03358.x","volume":"26","author":"EM Van Soest","year":"2007","unstructured":"Van Soest EM, Sturkenboom MC, Dielman JP, Verhamme KM, Siersema PD, Kuipers EJ (2007) Adherence to Gastroprotection and the Risk of NSAID-Related Upper Gastrointestinal Ulcers and Haemorrhage. Aliment Pharmacol Ther 26(2):265\u2013275","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"127_CR19","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.106.181424","volume":"115","author":"EM Antman","year":"2007","unstructured":"Antman EM, Bennett JS, Daugherty A et al (2007) Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 115(12):1634\u20131642","journal-title":"Circulation"},{"issue":"13","key":"127_CR20","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.296.13.jed60058","volume":"296","author":"DJ Graham","year":"2006","unstructured":"Graham DJ (2006) COX-2 inhibitors, other NSAIDs, and cardiovascular risk: the seduction of common sense. JAMA 296(13):1653\u20131656","journal-title":"JAMA"},{"issue":"2","key":"127_CR21","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1053\/j.gastro.2007.01.017","volume":"132","author":"D Henry","year":"2007","unstructured":"Henry D, McGettigan P (2007) Selective COX-2 inhibitors: a promise unfulfilled? Gastroenterology 132(2):790\u2013794","journal-title":"Gastroenterology"},{"issue":"11","key":"127_CR22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","volume":"338","author":"ND Yeomans","year":"1998","unstructured":"Yeomans ND, Tulassay Z, Juhasz L et al (1998) A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 338(11):719\u2013726","journal-title":"N Engl J Med"},{"issue":"11","key":"127_CR23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","volume":"338","author":"CJ Hawkey","year":"1998","unstructured":"Hawkey CJ, Karrasch JA, Szczepanski L et al (1998) Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 338(11):727\u2013734","journal-title":"N Engl J Med"},{"issue":"2","key":"127_CR24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2036.2000.00700.x","volume":"14","author":"DJ Cullen","year":"2000","unstructured":"Cullen DJ, Seager JM, Holmes S et al (2000) Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices. Aliment Pharmacol Ther 14(2):177\u2013185","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"127_CR25","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/00042737-199710000-00006","volume":"9","author":"A Pilotto","year":"1997","unstructured":"Pilotto A, Franceschi M, Leandro G et al (1997) The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly. Eur J Gastroenterol Hepatol 9(10):951\u2013956","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"127_CR26","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1365-2036.2004.02246.x","volume":"20","author":"A Pilotto","year":"2004","unstructured":"Pilotto A, Franceschi M, Leandro G et al (2004) Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin\/non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 20(10):1091\u20131097","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"127_CR27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/00365529609031975","volume":"31","author":"JM Hansen","year":"1996","unstructured":"Hansen JM, Hallas J, Lauritsen JM, Bytzer P (1996) Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making. Scand J Gastroenterol 31(2):126\u2013130","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"127_CR28","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0895-4356(00)00365-6","volume":"54","author":"L Rabeneck","year":"2001","unstructured":"Rabeneck L, Cook KF, Wristers K et al (2001) SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health. J Clin Epidemiol 54(8):755\u2013765","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"127_CR29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1572-0241.2002.05419.x","volume":"97","author":"L Rabeneck","year":"2002","unstructured":"Rabeneck L, Wristers K, Goldstein JL et al (2002) Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy. Am J Gastroenterol 97(1):32\u201339","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 3","key":"127_CR30","first-page":"iii32","volume":"42","author":"L Rabeneck","year":"2003","unstructured":"Rabeneck L (2003) Measuring dyspepsia-related health in randomized trials: the Severity of Dyspepsia Assessment (SODA) and its use in treatment with NSAIDs and COX-2-specific inhibitors. Rheumatology (Oxford) 42(Suppl 3):iii32\u2013iii39","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"127_CR31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2165\/00002018-199921060-00006","volume":"21","author":"GJ Brown","year":"1999","unstructured":"Brown GJ, Yeomans ND (1999) Prevention of the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: the role of proton pump inhibitors. Drug Saf 21(6):503\u2013512","journal-title":"Drug Saf"},{"issue":"1","key":"127_CR32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02090067","volume":"39","author":"JM Scheiman","year":"1994","unstructured":"Scheiman JM, Behler EM, Loeffler KM, Elta GH (1994) Omeprazole ameliorates aspirin-induced gastroduodenal injury. Dig Dis Sci 39(1):97\u2013103","journal-title":"Dig Dis Sci"},{"issue":"10","key":"127_CR33","first-page":"770","volume":"12","author":"MA Bigard","year":"1988","unstructured":"Bigard MA (1988) [Protective effect of omeprazole on gastric lesions induced by a single dose of aspirin in man]. Gastroenterol Clin Biol 12(10):770\u2013771","journal-title":"Gastroenterol Clin Biol"},{"issue":"1","key":"127_CR34","first-page":"43","volume":"30","author":"PG Bianchi","year":"1998","unstructured":"Bianchi PG, Lazzaroni M, Petrillo M et al (1998) Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study. Ital J Gastroenterol Hepatol 30(1):43\u201347","journal-title":"Ital J Gastroenterol Hepatol"},{"issue":"12","key":"127_CR35","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3109\/00365529209028136","volume":"27","author":"E Oddsson","year":"1992","unstructured":"Oddsson E, Gudjonsson H, Thjodleifsson B (1992) Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen. Scand J Gastroenterol 27(12):1045\u20131048","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"127_CR36","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/gut.31.5.514","volume":"31","author":"TK Daneshmend","year":"1990","unstructured":"Daneshmend TK, Stein AG, Bhaskar NK, Hawkey CJ (1990) Abolition by omeprazole of aspirin induced gastric mucosal injury in man. Gut 31(5):514\u2013517","journal-title":"Gut"},{"issue":"6","key":"127_CR37","first-page":"701","volume":"45","author":"B Simon","year":"1995","unstructured":"Simon B, Elsner H, Muller P (1995) [Protective effect of omeprazole against low-dose acetylsalicylic acid. Endoscopic controlled double-blind study in healthy subjects] Arzneimittelforschung 45(6):701\u2013703","journal-title":"Arzneimittelforschung"},{"issue":"6","key":"127_CR38","first-page":"758","volume":"47","author":"P Muller","year":"1997","unstructured":"Muller P, Fuchs W, Simon B (1997) [Studies on the protective effect of lansoprazole on human gastric mucosa against low-dose acetylsalicylic acid. An endoscopic controlled double-blind study]. Arzneimittelforschung 47(6):758\u2013760","journal-title":"Arzneimittelforschung"},{"issue":"4","key":"127_CR39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/clpt.1992.164","volume":"52","author":"JF Bergmann","year":"1992","unstructured":"Bergmann JF, Chassany O, Simoneau G et al (1992) Protection against aspirin-induced gastric lesions by lansoprazole: simultaneous evaluation of functional and morphologic responses. Clin Pharmacol Ther 52(4):413\u2013416","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"127_CR40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2036.1998.00288.x","volume":"12","author":"D Cullen","year":"1998","unstructured":"Cullen D, Bardhan KD, Eisner M et al (1998) Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Aliment Pharmacol Ther 12(2):135\u2013140","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"127_CR41","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/j.1572-0241.2006.00686.x","volume":"101","author":"J Regula","year":"2006","unstructured":"Regula J, Butruk E, Dekkers CP et al (2006) Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole. Am J Gastroenterol 101(8):1747\u20131755","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"127_CR42","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1023\/A:1010687115298","volume":"46","author":"G Leandro","year":"2001","unstructured":"Leandro G, Pilotto A, Franceschi M et al (2001) Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials. Dig Dis Sci 46(9):1924\u20131936","journal-title":"Dig Dis Sci"},{"issue":"4 Suppl","key":"127_CR43","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0885-3924(02)00368-8","volume":"23","author":"L Laine","year":"2002","unstructured":"Laine L (2002) Gastrointestinal safety of coxibs and outcomes studies: what's the verdict? J Pain Symptom Manage 23(4 Suppl):S5\u201310","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"127_CR44","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.clinthera.2006.03.007","volume":"28","author":"JL Goldstein","year":"2006","unstructured":"Goldstein JL, Aisenberg J, Lanza F et al (2006) A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65\u201375\u00a0years. Clin Ther 28(3):340\u2013351","journal-title":"Clin Ther"},{"issue":"8","key":"127_CR45","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/00365529609010347","volume":"31","author":"P Ekstr\u00f6m","year":"1996","unstructured":"Ekstr\u00f6m P, Carling L, Wetterhus S et al (1996) Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study. Scand J Gastroenterol 31(8):753\u2013758","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"127_CR46","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1365-2036.1996.29171000.x","volume":"10","author":"G Dorta","year":"1996","unstructured":"Dorta G, Nicolet M, Vouillamoz D et al (1996) Effects of misoprostol on healing and prevention of biopsy-induced gastroduodenal lesions occurring during the administration of diclofenac to volunteers. Aliment Pharmacol Ther 10(4):563\u2013569","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"127_CR47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1365-2125.2003.01934.x","volume":"56","author":"MW James","year":"2003","unstructured":"James MW, Hawkey CJ (2003) Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract. Br J Clin Pharmacol 56(2):146\u2013155","journal-title":"Br J Clin Pharmacol"},{"issue":"1 Pt 1","key":"127_CR48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0016-5085(85)80133-5","volume":"88","author":"PJ Prichard","year":"1985","unstructured":"Prichard PJ, Yeomans ND, Mihaly GW et al (1985) Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage. Gastroenterology 88(1 Pt 1):64\u201369","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-007-0127-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-007-0127-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-007-0127-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T15:43:40Z","timestamp":1559231020000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-007-0127-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,26]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1007\/s10620-007-0127-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,26]]}}}